Clinical trial

Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM

NCT02289235

Study summary

ClinicalTrials.gov

Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Ginger Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-05-01

PhaseEARLY_PHASE1

Conditions

Fatty Liververified · MONDO: fatty liver disease

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

GingerDRUG

PlaceboDRUG

Sponsors & collaborators

Shiraz University of Medical Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02289235 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.